Zhangyi Wang

Hengyang Normal University

Papers

1

Total Citations

2

H-Index

1

About

Dr. Zhangyi Wang is a leading researcher in gynecologic oncology and minimally invasive robotic surgery, with a particular focus on optimizing surgical outcomes for endometrial cancer. Their most cited work, a 2025 systematic review and meta-analysis comparing robotic single-site hysterectomy (RSSH) versus robotic multiport hysterectomy (RMPH), represents a significant contribution to evidence-based surgical practice. This study synthesizes data from multiple databases to evaluate the safety and efficacy of these two robotic approaches, providing crucial guidance for surgeons selecting the optimal technique for endometrial cancer patients. While still early in its citation trajectory, this meta-analysis has already garnered attention for addressing a key clinical question in the rapidly evolving field of robotic surgery. Dr. Wang’s research bridges the gap between technological innovation and clinical application, helping to define best practices in robotic hysterectomy. Their work is particularly valuable for surgical trainees and practicing oncologists seeking to understand the comparative benefits of single-site versus multiport robotic platforms. As robotic surgery continues to expand, Dr. Wang’s evidence-based analyses will remain essential reading for clinicians aiming to improve patient outcomes through minimally invasive techniques.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Robotic single site versus robotic multiport hysterectomy in endometrial cancer: a systematic review and meta-analysis
2 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 2
🏛 Institutions: Hengyang Normal University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago